← Back to catalogue

reSET® Introductory Access Limited Version

FDA UDI

Class II (US FDA UDI)

by Pear Therapeutics, Inc.

Identity

Trade Name
reSET® Introductory Access Limited Version FDA UDI
Generic Name
Mental health/function therapeutic software, screen-viewed FDA UDI
Device Name
reSET® is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Introductory Access Limited Version provides limited access to the reSET product. FDA UDI
Model / Reference
1 FDA UDI
Description
reSET® is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Introductory Access Limited Version provides limited access to the reSET product. FDA UDI

Identifiers

Primary DI / UDI-DI
10851580008132 FDA UDI
510(k) Number
FDA Product Code
PWE FDA UDI
GMDN Term
Mental health/function therapeutic software, screen-viewed FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.5801 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

reSET® Introductory Access Limited Version by Pear Therapeutics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI c5b8c305-9e5a-4d0e-8635-33455268c51d 35 fields · synced May 30, 2026